✦ LIBER ✦

ENIGMOL (2-AMINO-3,5-DIHYDROXYOCTADECANE [2S, 3S, 5S]) IS A NOVEL SPHINGOLIPID ANALOG THAT SHOWS A PROMISING EFFECT IN THE TREATMENT OF PROSTATE CANCER

✍ Scribed by Ramaraju, Harsha; Bushnev, Anatoly; Sun, Carrie Qi; Liotta, Dennis C; Merrill, Alfred H; Petros, John A

Book ID: 123094099
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 146 KB
Volume: 179
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(08)60138-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

236 GROWTH INHIBITORY EFFECTS OF ENIGMOL

236 GROWTH INHIBITORY EFFECTS OF ENIGMOL, (2-AMINO-3,5-DIHYDROXYOCTADECANE[2S,3S,5S]), ON ANDROGEN-DEPENDENT AND ANDROGEN-INDEPENDENT PROSTATE CANCER

✍ Mays, Suzanne; Ramaraju, Harsha; Bushnev, Anatoliy; Liotta, Dennis; Merrill, Alf 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 45 KB

Pharmacological characterisation and inh

Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A2A receptor agonist and adenosine A3 receptor antagonist activity

✍ Nicola Bevan; Peter R. Butchers; Rick Cousins; Jill Coates; Emma V. Edgar; Val M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 241 KB

2.445 A summary of the in vitro pharmaco

2.445 A summary of the in vitro pharmacology of pardoprunox (SLV308): A novel dopamine D2/D3 partial agonist and 5-HT1A agonist for the treatment of Parkinson's disease

✍ A. McCreary; J. Glennon; J.-H. Reinders; M. Hesselink; G. van Scharrenburg 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Bis(heteroaryl)piperazine (BHAP) reverse

Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogs and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)carbonyl]-4-[3-[(1-methylethyl)amino]pyridinyl]piperazinemonomethanesulfonate (U-90152S), a second-generation clinical candidate

✍ Romero, Donna L.; Morge, Raymond A.; Genin, Michael J.; Biles, Carolyn; Busso, M 📂 Article 📅 1993 🏛 American Chemical Society 🌐 English ⚖ 606 KB

Acetazolamide opens the muscular K3.0.CO

Acetazolamide opens the muscular K3.0.CO;2-A/asset/equation/tex2gif-inf-1.gif?v=1&t=h5mnxxo1&s=a3036156329ecd7af7add0fbdd623af613d683c8" class="inlineGraphic"> channel: A novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis

✍ Domenico Tricarico; Mariagrazia Barbieri; Diana Conte Camerino 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

Pantoprazole is superior to ranitidine i

Pantoprazole is superior to ranitidine in the treatment of florid duodenal ulcer, Mexican multicenter study: A. Barrera1, H. Barrera3, X. Diaz González4, M. Dibildox5, F. Esquivel1, R. Fischer5, S. Gallo1, F. León2, J. Naves2, G. Ochoa4, R. Omelas1, M. Ramos3, K. Rose5, E. Segura2 J. Tomás-Pons6. Instituto Nacional de la Nutrición Salvador Zubirán1, H. “20 de Noviembre” ISSSTE2, Mexico City. CMN de Occidente IMSS3, Guadalajara. H. San José ITESM4, Monterrey. Byk Gulden Germany5 Byk Gulden Mexico6

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 138 KB